Webinar: Role of UDP-Glucuronosyltransferases in Drug Metabolism and Drug-Drug Interactions
We are happy to announce the 3rd webinar in our non-CYP metabolism series! If you have not seen the 1st overview webinar, you may access the recording and slides here and the 2nd webinar on AO-mediated webinar is available here.
The importance of glucuronidation for metabolism of xenobiotics in humans is illustrated by the abundance and broad tissue distribution of the enzymes, the diversity of substrates and reactions catalyzed, as well as a number of distinctive UGT enzymes and their genetic polymorphisms… Read More
Register for the Live Webinar on October 5th at:
15:00 CEST / 9am EDT or 2pm EDT / 11am PDT
or to Only Receive a Link to the Recording & Slides After the Event (est. Sept. 3rd) with the Form Below:
About the Presenter:
Dr. Maciej Czerwinski currently serves as a Director in the Scientific Consulting department at SEKISUI XenoTech. He received his Ph.D. from the University of Maryland at Baltimore Medical School in the Department of Pathology. Dr. Czerwinksi conducted his doctoral thesis research in the Laboratory of Dr. Frank Gonzalez at the National Cancer Institute in Bethesda, followed by a post-doc at the Department of Pharmaceutics, the University of Washington in Seattle. He has been with SEKISUI XenoTech since 1999 and guides the development of products and services for the in vitro analysis of drug safety. Dr. Czerwinski designed a patented method to analyze the in vitro cytokine-mediated drug-drug interactions between biologics and small molecule drugs, and he is also the inventor of SEKISUI XenoTech’s CryostaX single-freeze pooled hepatocytes.